Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome
Movement Disorders · 2024
DOI: 10.1002/mds.29795 ↗Kurz gefasst
Fallbericht in der Zeitschrift Movement Disorders, 2024. Verfasst von Serena Galosi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Neuroscience, Sapienza University, Rome, Italy. Hauptthemen laut MEDLINE: Leigh Disease, Ketoglutarate Dehydrogenase Complex. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Background
The MRPS36 gene encodes a recently identified component of the 2‐oxoglutarate dehydrogenase complex (OGDHC), a key enzyme of the Krebs cycle catalyzing the oxidative decarboxylation of 2‐oxoglutarate to succinyl‐CoA. Defective OGDHC activity causes a clinically variable metabolic disorder characterized by global developmental delay, severe neurological impairment, liver failure, and early‐onset lactic acidosis.
Methods
We investigated the molecular cause underlying Leigh syndrome with bilateral striatal necrosis in two siblings through exome sequencing. Functional studies included measurement of the OGDHC enzymatic activity and MRPS36 mRNA levels in fibroblasts, assessment of protein stability in transfected cells, and structural analysis. A literature review was performed to define the etiological and phenotypic spectrum of OGDHC deficiency.
Results
In the two affected brothers, exome sequencing identified a homozygous nonsense variant (c.283G>T, p.Glu95*) of MRPS36. The variant did not affect transcript processing and stability, nor protein levels, but resulted in a shorter protein lacking nine residues that contribute to the structural and functional organization of the OGDHC complex. OGDHC enzymatic activity was significantly reduced. The review of previously reported cases of OGDHC deficiency supports the association of this enzymatic defect with Leigh phenotypic spectrum and early‐onset movement disorder. Slightly elevated plasma levels of glutamate and glutamine were observed in our and literature patients with OGDHC defect.
Conclusions
Our findings point to MRPS36 as a new disease gene implicated in Leigh syndrome. The slight elevation of plasma levels of glutamate and glutamine observed in patients with OGDHC deficiency represents a candidate metabolic signature of this neurometabolic disorder. © 2024 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Human Neuroscience, Sapienza University, Rome, Italy.
- Molecular Genetics and Functional Genomics, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy.
- Department of Chemical Science and Technologies, University of Rome Tor Vergata, Rome, Italy.
- Department of Experimental Medicine, Sapienza University, Rome, Italy.
- Translational Metabolic Laboratory, Department of Pediatrics, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy.
ORCID-Profile: Serena Galosi, Francesca Nardecchia
Zitieren
APA
Galosi, S., Mancini, C., Commone, A., Calligari, P., Caputo, V., Nardecchia, F., Carducci, C., van den Heuvel, L. P., Pizzi, S., Bruselles, A., Niceta, M., Martinelli, S., Rodenburg, R. J., Tartaglia, M., & Leuzzi, V. (2024). Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome. Movement Disorders. https://doi.org/10.1002/mds.29795
Vancouver
Galosi S, Mancini C, Commone A, Calligari P, Caputo V, Nardecchia F, et al. Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome. Movement Disorders. 2024. doi:10.1002/mds.29795
BibTeX
@article{Galosi2024,
author = {Galosi, Serena and Mancini, Cecilia and Commone, Anna and Calligari, Paolo and Caputo, Viviana and Nardecchia, Francesca and Carducci, Claudia and van den Heuvel, Lambertus P and Pizzi, Simone and Bruselles, Alessandro and Niceta, Marcello and Martinelli, Simone and Rodenburg, Richard J and Tartaglia, Marco and Leuzzi, Vincenzo},
title = {Biallelic Variants of MRPS36 Cause a New Form of Leigh Syndrome},
journal = {Movement Disorders},
year = {2024},
doi = {10.1002/mds.29795}
}
EUVIMED